Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
| Cat. No. | Especies | Descripción del producto | Estructura | Pureza | Característica |
|---|---|---|---|---|---|
| ALG-H52E1 | Human | Biotinylated Human ALPG / ALPPL2 Protein, His,Avitag™ (MALS verified) |  |
|
|
| ALG-M52H9 | Mouse | Mouse ALPG / ALPPL2 Protein, His Tag (MALS verified) |  |
|
|
| ALG-H52H9 | Human | Human ALPG / ALPPL2 Protein, His Tag (MALS verified) |  |
|
Immobilized Human ALPG, His Tag (Cat. No. ALG-H52H9) at 1 μg/mL (100 μL/well) can bind Anti - ALPG / ALPPL2 with a linear range of 0.002-0.125 μg/mL (QC tested).
The purity of Biotinylated Human ALPG Protein, His,Avitag (Cat. No. ALG-H52E1) is more than 90% and the molecular weight of this protein is around 115-135 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Amifostine | NSC-296961; YM-08310; S-8744; SAPEP; WR-2721; WR-2721C | Approved | Medimmune Llc | 天地达, 安福定, Ethyol | United States | Head and Neck Neoplasms; Ovarian Neoplasms | Clinigen Inc | 1995-12-08 | Cytoprotective adjuvant; Myelodysplastic-Myeloproliferative Diseases; Salivary Gland Diseases; Mucositis; Lymphoma; Lymphoma, Non-Hodgkin; Lung Neoplasms; Bone Marrow Diseases; Sarcoma; Acute Radiation Syndrome; Breast Neoplasms; Prostatic Neoplasms; Gestational Trophoblastic Disease; Radiation Injuries; Head and Neck Neoplasms; Nasopharyngeal Neoplasms; Fanconi Anemia; Hodgkin Disease; Small Cell Lung Carcinoma; Myelodysplastic Syndromes; Neutropenia; Carcinoma; Peripheral Nervous System Diseases; Trigeminal Neuralgia; Solid tumours; Ovarian Neoplasms; Drug-Related Side Effects and Adverse Reactions | Details |
| Amifostine | NSC-296961; YM-08310; S-8744; SAPEP; WR-2721; WR-2721C | Approved | Medimmune Llc | 天地达, 安福定, Ethyol | United States | Head and Neck Neoplasms; Ovarian Neoplasms | Clinigen Inc | 1995-12-08 | Cytoprotective adjuvant; Myelodysplastic-Myeloproliferative Diseases; Salivary Gland Diseases; Mucositis; Lymphoma; Lymphoma, Non-Hodgkin; Lung Neoplasms; Bone Marrow Diseases; Sarcoma; Acute Radiation Syndrome; Breast Neoplasms; Prostatic Neoplasms; Gestational Trophoblastic Disease; Radiation Injuries; Head and Neck Neoplasms; Nasopharyngeal Neoplasms; Fanconi Anemia; Hodgkin Disease; Small Cell Lung Carcinoma; Myelodysplastic Syndromes; Neutropenia; Carcinoma; Peripheral Nervous System Diseases; Trigeminal Neuralgia; Solid tumours; Ovarian Neoplasms; Drug-Related Side Effects and Adverse Reactions | Details |
This web search service is supported by Google Inc.
A-Z
